Department of Internal Medicine,
Division of Nephrology,
Department of Internal Medicine, Division of Nephrology
Vicente E. Torres has not added Biography.
If you are Vicente E. Torres and would like to personalize this page please email our Author Liaison for assistance.
Epidermal growth factor receptor tyrosine kinase inhibition is not protective in PCK rats.
Kidney international Nov, 2004 | Pubmed ID: 15496147
The gene mutated in autosomal recessive polycystic kidney disease encodes a large, receptor-like protein.
Nature genetics Mar, 2002 | Pubmed ID: 11919560
The position of the polycystic kidney disease 1 (PKD1) gene mutation correlates with the severity of renal disease.
Journal of the American Society of Nephrology : JASN May, 2002 | Pubmed ID: 11961010
A complete mutation screen of the ADPKD genes by DHPLC.
Kidney international May, 2002 | Pubmed ID: 11967008
Clinical profile of autosomal dominant polycystic liver disease.
Hepatology (Baltimore, Md.) Jan, 2003 | Pubmed ID: 12500201
The ENOS polymorphism is not associated with severity of renal disease in polycystic kidney disease 1.
American journal of kidney diseases : the official journal of the National Kidney Foundation Jan, 2003 | Pubmed ID: 12500225
Mutations in PRKCSH cause isolated autosomal dominant polycystic liver disease.
American journal of human genetics Mar, 2003 | Pubmed ID: 12529853
PKHDL1, a homolog of the autosomal recessive polycystic kidney disease gene, encodes a receptor with inducible T lymphocyte expression.
Human molecular genetics Mar, 2003 | Pubmed ID: 12620974
Association of mutation position in polycystic kidney disease 1 (PKD1) gene and development of a vascular phenotype.
Lancet (London, England) Jun, 2003 | Pubmed ID: 12842373
A complete mutation screen of PKHD1 in autosomal-recessive polycystic kidney disease (ARPKD) pedigrees.
Kidney international Aug, 2003 | Pubmed ID: 12846734
Pkd2 haploinsufficiency alters intracellular calcium regulation in vascular smooth muscle cells.
Human molecular genetics Aug, 2003 | Pubmed ID: 12874107
Renal structure in early autosomal-dominant polycystic kidney disease (ADPKD): The Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) cohort.
Kidney international Sep, 2003 | Pubmed ID: 12911554
Cellular and subcellular localization of the ARPKD protein; fibrocystin is expressed on primary cilia.
Human molecular genetics Oct, 2003 | Pubmed ID: 12925574
Analysis of the polycystins in aortic vascular smooth muscle cells.
Journal of the American Society of Nephrology : JASN Sep, 2003 | Pubmed ID: 12937304
Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist.
Nature medicine Oct, 2003 | Pubmed ID: 14502283
EGF receptor tyrosine kinase inhibition attenuates the development of PKD in Han:SPRD rats.
Kidney international Nov, 2003 | Pubmed ID: 14531789
Defects in cholangiocyte fibrocystin expression and ciliary structure in the PCK rat.
Gastroenterology Nov, 2003 | Pubmed ID: 14598246
Magnetic resonance measurements of renal blood flow as a marker of disease severity in autosomal-dominant polycystic kidney disease.
Kidney international Dec, 2003 | Pubmed ID: 14633145
Effective treatment of an orthologous model of autosomal dominant polycystic kidney disease.
Nature medicine Apr, 2004 | Pubmed ID: 14991049
Follow-up of intracranial aneurysms in autosomal-dominant polycystic kidney disease.
Kidney international May, 2004 | Pubmed ID: 15086900
Mutations in SEC63 cause autosomal dominant polycystic liver disease.
Nature genetics Jun, 2004 | Pubmed ID: 15133510
Therapies to slow polycystic kidney disease.
Nephron. Experimental nephrology , 2004 | Pubmed ID: 15361692
Biliary dysgenesis in the PCK rat, an orthologous model of autosomal recessive polycystic kidney disease.
The American journal of pathology Nov, 2004 | Pubmed ID: 15509540
Haplotype analysis improves molecular diagnostics of autosomal recessive polycystic kidney disease.
American journal of kidney diseases : the official journal of the National Kidney Foundation Jan, 2005 | Pubmed ID: 15696446
Effectiveness of vasopressin V2 receptor antagonists OPC-31260 and OPC-41061 on polycystic kidney disease development in the PCK rat.
Journal of the American Society of Nephrology : JASN Apr, 2005 | Pubmed ID: 15728778
[Ca2+]i reduction increases cellular proliferation and apoptosis in vascular smooth muscle cells: relevance to the ADPKD phenotype.
Circulation research Apr, 2005 | Pubmed ID: 15790956
Vasopressin antagonists in polycystic kidney disease.
Kidney international Nov, 2005 | Pubmed ID: 16221255
Sonographic assessment of the severity and progression of autosomal dominant polycystic kidney disease: the Consortium of Renal Imaging Studies in Polycystic Kidney Disease (CRISP).
American journal of kidney diseases : the official journal of the National Kidney Foundation Dec, 2005 | Pubmed ID: 16310571
The transmembrane protein meckelin (MKS3) is mutated in Meckel-Gruber syndrome and the wpk rat.
Nature genetics Feb, 2006 | Pubmed ID: 16415887
Comparison of methods for determining renal function decline in early autosomal dominant polycystic kidney disease: the consortium of radiologic imaging studies of polycystic kidney disease cohort.
Journal of the American Society of Nephrology : JASN Mar, 2006 | Pubmed ID: 16452494
Clinical and molecular characterization defines a broadened spectrum of autosomal recessive polycystic kidney disease (ARPKD).
Medicine Jan, 2006 | Pubmed ID: 16523049
Volume progression in polycystic kidney disease.
The New England journal of medicine May, 2006 | Pubmed ID: 16707749
Understanding pathogenic mechanisms in polycystic kidney disease provides clues for therapy.
Current opinion in nephrology and hypertension Jul, 2006 | Pubmed ID: 16775462
Water for ADPKD? Probably, yes.
Journal of the American Society of Nephrology : JASN Aug, 2006 | Pubmed ID: 16837639
Autosomal recessive polycystic kidney disease and congenital hepatic fibrosis: summary statement of a first National Institutes of Health/Office of Rare Diseases conference.
The Journal of pediatrics Aug, 2006 | Pubmed ID: 16887426
Mechanisms of Disease: autosomal dominant and recessive polycystic kidney diseases.
Nature clinical practice. Nephrology Jan, 2006 | Pubmed ID: 16932388
Duodenal diverticulosis in autosomal dominant polycystic kidney disease.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association Dec, 2006 | Pubmed ID: 16951424
Cyst number but not the rate of cystic growth is associated with the mutated gene in autosomal dominant polycystic kidney disease.
Journal of the American Society of Nephrology : JASN Nov, 2006 | Pubmed ID: 17035604
Autosomal dominant polycystic kidney disease coexisting with cystic fibrosis.
Journal of nephrology Jul-Aug, 2006 | Pubmed ID: 17048214
Cerebral aneurysms.
The New England journal of medicine Dec, 2006 | Pubmed ID: 17186587
Molecular diagnostics of Meckel-Gruber syndrome highlights phenotypic differences between MKS1 and MKS3.
Human genetics Jun, 2007 | Pubmed ID: 17377820
Octreotide inhibits hepatic cystogenesis in a rodent model of polycystic liver disease by reducing cholangiocyte adenosine 3',5'-cyclic monophosphate.
Gastroenterology Mar, 2007 | Pubmed ID: 17383431
Retinal arterial and venous occlusions in patients with ADPKD.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association Jun, 2007 | Pubmed ID: 17403703
Autosomal dominant polycystic kidney disease.
Lancet (London, England) Apr, 2007 | Pubmed ID: 17434405
Inferior vena cava stenting: a safe and effective treatment for intractable ascites in patients with polycystic liver disease.
Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract Aug, 2007 | Pubmed ID: 17508255
Treatment of polycystic liver disease: one size does not fit all.
American journal of kidney diseases : the official journal of the National Kidney Foundation Jun, 2007 | Pubmed ID: 17533013
Comprehensive molecular diagnostics in autosomal dominant polycystic kidney disease.
Journal of the American Society of Nephrology : JASN Jul, 2007 | Pubmed ID: 17582161
Quantitative assessment of hepatic fibrosis in an animal model with magnetic resonance elastography.
Magnetic resonance in medicine Aug, 2007 | Pubmed ID: 17654577
Magnetic resonance imaging evaluation of hepatic cysts in early autosomal-dominant polycystic kidney disease: the Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease cohort.
Clinical journal of the American Society of Nephrology : CJASN Jan, 2006 | Pubmed ID: 17699192
Volume progression in autosomal dominant polycystic kidney disease: the major factor determining clinical outcomes.
Clinical journal of the American Society of Nephrology : CJASN Jan, 2006 | Pubmed ID: 17699202
Magnetic resonance measurements of renal blood flow and disease progression in autosomal dominant polycystic kidney disease.
Clinical journal of the American Society of Nephrology : CJASN Jan, 2007 | Pubmed ID: 17699395
Increased occurrence of pericardial effusion in patients with autosomal dominant polycystic kidney disease.
Clinical journal of the American Society of Nephrology : CJASN Nov, 2007 | Pubmed ID: 17928471
Vasopressin directly regulates cyst growth in polycystic kidney disease.
Journal of the American Society of Nephrology : JASN Jan, 2008 | Pubmed ID: 18032793
Sirolimus reduces polycystic liver volume in ADPKD patients.
Journal of the American Society of Nephrology : JASN Mar, 2008 | Pubmed ID: 18199797
Role of vasopressin antagonists.
Clinical journal of the American Society of Nephrology : CJASN Jul, 2008 | Pubmed ID: 18434616
Vasopressin antagonists in polycystic kidney disease.
Seminars in nephrology May, 2008 | Pubmed ID: 18519091
What the similarities of specific polycystic liver and kidney diseases can teach us about both.
Nephrology news & issues Aug, 2008 | Pubmed ID: 18778002
Characterization of large rearrangements in autosomal dominant polycystic kidney disease and the PKD1/TSC2 contiguous gene syndrome.
Kidney international Dec, 2008 | Pubmed ID: 18818683
Effect of calcium-sensing receptor activation in models of autosomal recessive or dominant polycystic kidney disease.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association Feb, 2009 | Pubmed ID: 18826972
Polycystic kidney disease.
Annual review of medicine , 2009 | Pubmed ID: 18947299
Characterization of PKD protein-positive exosome-like vesicles.
Journal of the American Society of Nephrology : JASN Feb, 2009 | Pubmed ID: 19158352
Incompletely penetrant PKD1 alleles suggest a role for gene dosage in cyst initiation in polycystic kidney disease.
Kidney international Apr, 2009 | Pubmed ID: 19165178
MRI-based kidney volume measurements in ADPKD: reliability and effect of gadolinium enhancement.
Clinical journal of the American Society of Nephrology : CJASN Apr, 2009 | Pubmed ID: 19339416
A case for water in the treatment of polycystic kidney disease.
Clinical journal of the American Society of Nephrology : CJASN Jun, 2009 | Pubmed ID: 19443627
Autosomal dominant polycystic kidney disease: the last 3 years.
Kidney international Jul, 2009 | Pubmed ID: 19455193
Ciliary and centrosomal defects associated with mutation and depletion of the Meckel syndrome genes MKS1 and MKS3.
Human molecular genetics Sep, 2009 | Pubmed ID: 19515853
Type II calcimimetics and polycystic kidney disease: unanswered questions.
Journal of the American Society of Nephrology : JASN Jul, 2009 | Pubmed ID: 19520753
Polycystic liver disease: a critical appraisal of hepatic resection, cyst fenestration, and liver transplantation.
Annals of surgery Jul, 2009 | Pubmed ID: 19561475
Vasopressin in chronic kidney disease: an elephant in the room?
Kidney international Nov, 2009 | Pubmed ID: 19829311
Percutaneous nephrolithotomy for large or multiple upper tract calculi and autosomal dominant polycystic kidney disease.
The Journal of urology Jan, 2010 | Pubmed ID: 19913818
Cyclic nucleotide signaling in polycystic kidney disease.
Kidney international Jan, 2010 | Pubmed ID: 19924104
The HALT polycystic kidney disease trials: design and implementation.
Clinical journal of the American Society of Nephrology : CJASN Jan, 2010 | Pubmed ID: 20089507
Treatment strategies and clinical trial design in ADPKD.
Advances in chronic kidney disease Mar, 2010 | Pubmed ID: 20219622
Renal arterial blood flow measurement by breath-held MRI: Accuracy in phantom scans and reproducibility in healthy subjects.
Magnetic resonance in medicine Apr, 2010 | Pubmed ID: 20373395
Randomized clinical trial of long-acting somatostatin for autosomal dominant polycystic kidney and liver disease.
Journal of the American Society of Nephrology : JASN Jun, 2010 | Pubmed ID: 20431041
Prospects for mTOR inhibitor use in patients with polycystic kidney disease and hamartomatous diseases.
Clinical journal of the American Society of Nephrology : CJASN Jul, 2010 | Pubmed ID: 20498248
Incompletely penetrant PKD1 alleles mimic the renal manifestations of ARPKD.
Journal of the American Society of Nephrology : JASN Jul, 2010 | Pubmed ID: 20558538
Genetic variation of DKK3 may modify renal disease severity in ADPKD.
Journal of the American Society of Nephrology : JASN Sep, 2010 | Pubmed ID: 20616171
Equations to estimate creatinine excretion rate: the CKD epidemiology collaboration.
Clinical journal of the American Society of Nephrology : CJASN Jan, 2011 | Pubmed ID: 20966119
Pioglitazone Attenuates Cystic Burden in the PCK Rodent Model of Polycystic Kidney Disease.
PPAR research , 2010 | Pubmed ID: 21052534
Potentially modifiable factors affecting the progression of autosomal dominant polycystic kidney disease.
Clinical journal of the American Society of Nephrology : CJASN Mar, 2011 | Pubmed ID: 21088290
Medical and surgical treatment options for polycystic liver disease.
Hepatology (Baltimore, Md.) Dec, 2010 | Pubmed ID: 21105111
Germline PKHD1 mutations are protective against colorectal cancer.
Human genetics Mar, 2011 | Pubmed ID: 21274727
Rationale and design of the TEMPO (Tolvaptan Efficacy and Safety in Management of Autosomal Dominant Polycystic Kidney Disease and its Outcomes) 3-4 Study.
American journal of kidney diseases : the official journal of the National Kidney Foundation May, 2011 | Pubmed ID: 21333426
Short-term reproducibility of ambulatory blood pressure monitoring in autosomal dominant polycystic kidney disease.
Blood pressure monitoring Apr, 2011 | Pubmed ID: 21415814
B9D1 is revealed as a novel Meckel syndrome (MKS) gene by targeted exon-enriched next-generation sequencing and deletion analysis.
Human molecular genetics Jul, 2011 | Pubmed ID: 21493627
Short-term effects of tolvaptan on renal function and volume in patients with autosomal dominant polycystic kidney disease.
Kidney international Aug, 2011 | Pubmed ID: 21544064
Extended follow-up of unruptured intracranial aneurysms detected by presymptomatic screening in patients with autosomal dominant polycystic kidney disease.
Clinical journal of the American Society of Nephrology : CJASN Jun, 2011 | Pubmed ID: 21551026
Frequency of undiagnosed cystic lung disease in patients with sporadic renal angiomyolipomas.
Chest Jan, 2012 | Pubmed ID: 21737494
Fibrosis, regeneration, and aging: playing chess with evolution.
Journal of the American Society of Nephrology : JASN Aug, 2011 | Pubmed ID: 21757767
Cardiac magnetic resonance assessment of left ventricular mass in autosomal dominant polycystic kidney disease.
Clinical journal of the American Society of Nephrology : CJASN Oct, 2011 | Pubmed ID: 21903983
Tolvaptan in autosomal dominant polycystic kidney disease: three years' experience.
Clinical journal of the American Society of Nephrology : CJASN Oct, 2011 | Pubmed ID: 21903984
Epitope-tagged Pkhd1 tracks the processing, secretion, and localization of fibrocystin.
Journal of the American Society of Nephrology : JASN Dec, 2011 | Pubmed ID: 22021705
Polycystic kidney disease in 2011: Connecting the dots toward a polycystic kidney disease therapy.
Nature reviews. Nephrology Feb, 2012 | Pubmed ID: 22158473
Analysis of baseline parameters in the HALT polycystic kidney disease trials.
Kidney international Mar, 2012 | Pubmed ID: 22205355
Kidney volume and functional outcomes in autosomal dominant polycystic kidney disease.
Clinical journal of the American Society of Nephrology : CJASN Mar, 2012 | Pubmed ID: 22344503
Identification of gene mutations in autosomal dominant polycystic kidney disease through targeted resequencing.
Journal of the American Society of Nephrology : JASN May, 2012 | Pubmed ID: 22383692
Characteristics of renal cystic and solid lesions based on contrast-enhanced computed tomography of potential kidney donors.
American journal of kidney diseases : the official journal of the National Kidney Foundation May, 2012 | Pubmed ID: 22398108
Somatostatin analog therapy for severe polycystic liver disease: results after 2 years.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association Sep, 2012 | Pubmed ID: 22773240
Insignificant effect of secretin in rodent models of polycystic kidney and liver disease.
American journal of physiology. Renal physiology Oct, 2012 | Pubmed ID: 22811488
Cardiovascular consequences of new-onset hyperglycemia after kidney transplantation.
Transplantation Jul, 2012 | Pubmed ID: 22820698
Functional polycystin-1 dosage governs autosomal dominant polycystic kidney disease severity.
The Journal of clinical investigation Nov, 2012 | Pubmed ID: 23064367
Relationship of copeptin, a surrogate marker for arginine vasopressin, with change in total kidney volume and GFR decline in autosomal dominant polycystic kidney disease: results from the CRISP cohort.
American journal of kidney diseases : the official journal of the National Kidney Foundation Mar, 2013 | Pubmed ID: 23089511
Tolvaptan in patients with autosomal dominant polycystic kidney disease.
The New England journal of medicine Dec, 2012 | Pubmed ID: 23121377
Pasireotide is more effective than octreotide in reducing hepatorenal cystogenesis in rodents with polycystic kidney and liver diseases.
Hepatology (Baltimore, Md.) Jul, 2013 | Pubmed ID: 23172758
Urinary proteomic biomarkers for diagnosis and risk stratification of autosomal dominant polycystic kidney disease: a multicentric study.
PloS one , 2013 | Pubmed ID: 23326375
Polycystin-2 mutations lead to impaired calcium cycling in the heart and predispose to dilated cardiomyopathy.
Journal of molecular and cellular cardiology May, 2013 | Pubmed ID: 23376035
Segmentation of individual renal cysts from MR images in patients with autosomal dominant polycystic kidney disease.
Clinical journal of the American Society of Nephrology : CJASN Jul, 2013 | Pubmed ID: 23520042
Tolvaptan in autosomal dominant polycystic kidney disease.
The New England journal of medicine Mar, 2013 | Pubmed ID: 23534568
Inhibition of Comt with tolcapone slows progression of polycystic kidney disease in the more severely affected PKD/Mhm (cy/+) substrain of the Hannover Sprague-Dawley rat.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association Aug, 2013 | Pubmed ID: 23543593
Young women with polycystic liver disease respond best to somatostatin analogues: a pooled analysis of individual patient data.
Gastroenterology Aug, 2013 | Pubmed ID: 23665274
Osmoregulation, vasopressin, and cAMP signaling in autosomal dominant polycystic kidney disease.
Current opinion in nephrology and hypertension Jul, 2013 | Pubmed ID: 23736843
Evidence of a third ADPKD locus is not supported by re-analysis of designated PKD3 families.
Kidney international Feb, 2014 | Pubmed ID: 23760289
Experimental therapies and ongoing clinical trials to slow down progression of ADPKD.
Current hypertension reviews Feb, 2013 | Pubmed ID: 23971644
Novel approach to estimate kidney and cyst volumes using mid-slice magnetic resonance images in polycystic kidney disease.
American journal of nephrology , 2013 | Pubmed ID: 24107679
Health-related quality of life in patients with autosomal dominant polycystic kidney disease and CKD stages 1-4: a cross-sectional study.
American journal of kidney diseases : the official journal of the National Kidney Foundation Feb, 2014 | Pubmed ID: 24183837
Transition fibre protein FBF1 is required for the ciliary entry of assembled intraflagellar transport complexes.
Nature communications , 2013 | Pubmed ID: 24231678
Evaluating health-related quality of life in patients with polycystic liver disease and determining the impact of symptoms and liver volume.
Liver international : official journal of the International Association for the Study of the Liver Nov, 2014 | Pubmed ID: 24313956
Strategies targeting cAMP signaling in the treatment of polycystic kidney disease.
Journal of the American Society of Nephrology : JASN Jan, 2014 | Pubmed ID: 24335972
Rationale and design of the DIPAK 1 study: a randomized controlled clinical trial assessing the efficacy of lanreotide to Halt disease progression in autosomal dominant polycystic kidney disease.
American journal of kidney diseases : the official journal of the National Kidney Foundation Mar, 2014 | Pubmed ID: 24342522
Aberrant expression of laminin-332 promotes cell proliferation and cyst growth in ARPKD.
American journal of physiology. Renal physiology Mar, 2014 | Pubmed ID: 24370592
Novel methodology to evaluate renal cysts in polycystic kidney disease.
American journal of nephrology , 2014 | Pubmed ID: 24576800
The cleaved cytoplasmic tail of polycystin-1 regulates Src-dependent STAT3 activation.
Journal of the American Society of Nephrology : JASN Aug, 2014 | Pubmed ID: 24578126
Supervised segmentation of polycystic kidneys: a new application for stereology data.
Journal of digital imaging Aug, 2014 | Pubmed ID: 24639063
Phosphodiesterase 1A modulates cystogenesis in zebrafish.
Journal of the American Society of Nephrology : JASN Oct, 2014 | Pubmed ID: 24700876
Genetic mechanisms and signaling pathways in autosomal dominant polycystic kidney disease.
The Journal of clinical investigation Jun, 2014 | Pubmed ID: 24892705
Filling the holes in cystic kidney disease research.
Clinical journal of the American Society of Nephrology : CJASN Oct, 2014 | Pubmed ID: 24903391
Imaging classification of autosomal dominant polycystic kidney disease: a simple model for selecting patients for clinical trials.
Journal of the American Society of Nephrology : JASN Jan, 2015 | Pubmed ID: 24904092
Tolvaptan plus pasireotide shows enhanced efficacy in a PKD1 model.
Journal of the American Society of Nephrology : JASN Jan, 2015 | Pubmed ID: 24994926
Liver involvement in early autosomal-dominant polycystic kidney disease.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association Jan, 2015 | Pubmed ID: 25111236
Angiotensin blockade in late autosomal dominant polycystic kidney disease.
The New England journal of medicine Dec, 2014 | Pubmed ID: 25399731
Blood pressure in early autosomal dominant polycystic kidney disease.
The New England journal of medicine Dec, 2014 | Pubmed ID: 25399733
Novel therapeutic approaches to autosomal dominant polycystic kidney disease.
Translational research : the journal of laboratory and clinical medicine Apr, 2015 | Pubmed ID: 25438190
Identification of Biomarkers for PKD1 Using Urinary Exosomes.
Journal of the American Society of Nephrology : JASN Dec, 2014 | Pubmed ID: 25475747
Vasopressin receptor antagonists, heart failure, and polycystic kidney disease.
Annual review of medicine , 2015 | Pubmed ID: 25493947
Effects of hydration in rats and mice with polycystic kidney disease.
American journal of physiology. Renal physiology Feb, 2015 | Pubmed ID: 25503729
The effect of tolvaptan on autosomal dominant polycystic kidney disease patients: a subgroup analysis of the Japanese patient subset from TEMPO 3:4 trial.
Clinical and experimental nephrology Feb, 2015 | Pubmed ID: 25663351
Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
Kidney international Mar, 2015 | Pubmed ID: 25786098
A comparison of ultrasound and magnetic resonance imaging shows that kidney length predicts chronic kidney disease in autosomal dominant polycystic kidney disease.
Kidney international Apr, 2015 | Pubmed ID: 25830764
Vasopressin and disruption of calcium signalling in polycystic kidney disease.
Nature reviews. Nephrology Apr, 2015 | Pubmed ID: 25870007
The Future of Polycystic Kidney Disease Research-As Seen By the 12 Kaplan Awardees.
Journal of the American Society of Nephrology : JASN May, 2015 | Pubmed ID: 25952256
Utilizing magnetization transfer imaging to investigate tissue remodeling in a murine model of autosomal dominant polycystic kidney disease.
Magnetic resonance in medicine : official journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine May, 2015 | Pubmed ID: 25974140
Volume regression of native polycystic kidneys after renal transplantation.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association Jun, 2015 | Pubmed ID: 26044834
Therapeutic Area Data Standards for Autosomal Dominant Polycystic Kidney Disease: A Report From the Polycystic Kidney Disease Outcomes Consortium (PKDOC).
American journal of kidney diseases : the official journal of the National Kidney Foundation Jun, 2015 | Pubmed ID: 26088508